Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2015 | 07-2015 | 04-2015 | 01-2015 | 10-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 171 | 156 | 119 | 345 | 426 |
| Marketable Securities | 2,151 | 2,662 | 1,966 | 2,276 | 2,711 |
| Receivables | 177 | 147 | 98 | 9 | 105 |
| TOTAL | $2,518 | $3,053 | $2,195 | $2,646 | $3,280 |
| Non-Current Assets | |||||
| PPE Net | 24 | 11 | 12 | 14 | 14 |
| Intangibles | 0 | 0 | 0 | 193 | 398 |
| TOTAL | $24 | $11 | $12 | $207 | $411 |
| Total Assets | $2,541 | $3,065 | $2,207 | $2,853 | $3,691 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 161 | 131 | 197 | 124 | 220 |
| TOTAL | $161 | $131 | $197 | $124 | $220 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $161 | $131 | $197 | $124 | $220 |
| Shareholders' Equity | |||||
| Common Shares | 23,039 | 22,909 | 21,374 | 22,944 | 24,512 |
| Retained earnings | -23,897 | -23,114 | -22,494 | -23,565 | -24,597 |
| Other shareholders' equity | 754 | 751 | 282 | 794 | 848 |
| TOTAL | $2,380 | $2,934 | $2,011 | $2,729 | $3,471 |
| Total Liabilities And Equity | $2,541 | $3,065 | $2,207 | $2,853 | $3,691 |